The Politics of Fear

Total Page:16

File Type:pdf, Size:1020Kb

The Politics of Fear The Politics of Fear The Politics of Fear Médecins Sans Frontières and the West African Ebola Epidemic EDITED BY MICHIEL HOFMAN and SOKHIENG AU 1 1 Oxford University Press is a department of the University of Oxford. It furthers the University’s objective of excellence in research, scholarship, and education by publishing worldwide. Oxford is a registered trade mark of Oxford University Press in the UK and certain other countries. Published in the United States of America by Oxford University Press 198 Madison Avenue, New York, NY 10016, United States of America. © Oxford University Press 2017 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, without the prior permission in writing of Oxford University Press, or as expressly permitted by law, by license, or under terms agreed with the appropriate reproduction rights organization. Inquiries concerning reproduction outside the scope of the above should be sent to the Rights Department, Oxford University Press, at the address above. You must not circulate this work in any other form and you must impose this same condition on any acquirer. Library of Congress Cataloging- in- Publication Data Names: Hofman, Michiel, editor. | Au, Sokhieng, editor. Title: The politics of fear : Médecins Sans Frontières and the West African Ebola epidemic / edited by Michiel Hofman and Sokhieng Au. Description: Oxford : Oxford University Press, [2016] | Includes bibliographical references and index. Identifiers: LCCN 2016027983 (print) | LCCN 2016042202 (ebook) | ISBN 9780190624477 (hardcover : alk. paper) | ISBN 9780190624484 (ebook) | ISBN 9780190624491 (ebook) Subjects: LCSH: Ebola virus disease—Africa, West. | Ebola virus disease—Social aspects—Africa, West. | Ebola virus disease—Political aspects—Africa, West. | Epidemics—Social aspects—Africa, West. | Epidemics—Political aspects—Africa, West. | Médecins Sans frontières (Association) | Africa, West—Social conditions. Classification: LCC RC140.5 .P65 2016 (print) | LCC RC140.5 (ebook) | DDC 362.196/92—dc23 LC record available at https://lccn.loc.gov/2016027983 This material is not intended to be, and should not be considered, a substitute for medical or other professional advice. Treatment for the conditions described in this material is highly dependent on the individual circumstances. And, while this material is designed to offer accurate information with respect to the subject matter covered and to be current as of the time it was written, research and knowledge about medical and health issues is constantly evolving and dose schedules for medications are being revised continually, with new side effects recognized and accounted for regularly. Readers must therefore always check the product information and clinical procedures with the most up-to-date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulation. The publisher and the authors make no representations or warranties to readers, express or implied, as to the accuracy or completeness of this material. Without limiting the foregoing, the publisher and the authors make no representations or warranties as to the accuracy or efficacy of the drug dosages mentioned in the material. The authors and the publisher do not accept, and expressly disclaim, any responsibility for any liability, loss or risk that may be claimed or incurred as a consequence of the use and/or application of any of the contents of this material. 1 3 5 7 9 8 6 4 2 Printed by Sheridan Books, Inc., United States of America CONTENTS Preface vii Christopher Stokes Contributors xi Introduction xv Michiel Hofman and Sokhieng Au THE RESPONSE 1. Doctors Against Borders: Médecins Sans Frontières and Global Health Security 3 João Nunes 2. Whose Security? Militarization and Securitization During West Africa’s Ebola Outbreak 25 Adia Benton Vignette 1. A Few Days in July Lindis Hurum THE SYSTEM 3. The “Humanitarian” Response to the Ebola Epidemic in Guinea: Between Routines and Exceptions 63 Jean- Francois Caremel, Sylvain Landry B. Faye, and Ramatou Ouedraogo v vi Contents 4. The Initial International Aid Response in Sierra Leone: A Viewpoint from the Field 85 Thomas Kratz 5. Dying of the Mundane in the Time of Ebola: The Effect of the Epidemic on Health and Disease in West Africa 101 Mit Philips Vignette 2. Treating, Suffering, and Surviving Ebola: The Story of Prince as told to Patricia Carrick Prince Lahai and Patricia Carrick PATIENTS 6. How Did Médecins Sans Frontières Negotiate Clinical Trials of Unproven Treatments During the 2014– 2015 Ebola Epidemic? 133 Annette Rid and Annick Antierens 7. Failing Dr. Khan 175 Tim O’Dempsey 8. Finding an Answer to Ebola’s Greatest Challenge 187 Armand Sprecher Vignette 3. Children in the Ebola Treatment Centers Allie Tua Lappia and Patricia Carrick CONTAINMENT 9. Fear and Containment: Contact Follow- up Perceptions and Social Effects in Senegal and Guinea 209 Alice Desclaux, Moustapha Diop, and Stéphane Doyon 10. Challenges of Instituting Effective Medevac Policies 235 Duncan McLean Vignette 4. Returning to the “Ebola World” Maud Santantonio Index 259 PREFACE With the clarity of hindsight, the word “unprecedented” is now firmly associated with the West African Ebola epidemic of 2014 and 2015. The figures speak for themselves: 25,213 cases were confirmed in the first year of the outbreak and 10,460 patients died. Health professionals deployed by MSF were not immune to the disease either: in the same period, 28 MSF staff were diagnosed with Ebola and 14 of them died. However, these cold figures do not show the tremen- dous impact this epidemic had, not only on those directly infected by the virus, but also on the societies through which the disease spread and on those who responded to the crisis. The world, including MSF, was slow to respond. All of us, without exception, underestimated how rapidly and how far the virus would spread. We also underestimated the scale of the efforts that would be needed to assist those affected and to control the epidemic. Prior to the West African outbreak, Ebola was a relatively rare disease that had limited local impact and that burned out fairly quickly. MSF, as one of the few agencies with direct experience responding to Ebola outbreaks in the past, had built up a level of expertise. As a result, from the first days of the epidemic, MSF found itself at the center of the response in West Africa. Nothing, however, had prepared MSF for what happened next in Guinea, Sierra Leone, and Liberia. The disease not only spread over a wide geographic region, but also, for the first time ever recorded, reached densely populated areas such as Monrovia and Conakry. MSF was severely challenged in recognizing the scale of this epidemic, and subsequently in scaling up the medical and human resources necessary to respond. The impact was profound. Not only did this epidemic push the medi- cal and logistical infrastructure of MSF to the limit, driving personnel at all levels to exhaustion, but it also severely strained MSF’s own ethical values, forcing staff into making daily decisions between poor, bad, and even worse options while lives were at stake. vii viii Preface Under these circumstances the usual cost/ benefit evaluations are worse than inadequate. This epidemic tested the political resolve and operational choices both inside and outside of MSF. It has left a legacy of lessons to be learned in terms of much- needed technical improvements but also forces us all to recon- sider how the world at large deals with transnational health emergencies. A per- vasive factor influencing the decisions made during this crisis was fear. To examine this theme, MSF has sponsored this book and made the unprecedented step of allowing the authors full access to the internal archives of MSF’s Ebola response in 2014 and 2015. The majority of the authors are external to MSF, providing a unique insight into the processes of fear that informed many of the decisions made by the politicians and the responders such as MSF. Not all aspects of the outbreak are covered in the 10 chapters. The authors made their own choices regarding which aspects they wanted to highlight, and most of the chapters will elaborate on the wider response, going beyond the spe- cific role played by MSF. This can give the impression that fear affected only others, while the fearless MSF “heroes” ventured into the epidemic with iron resolve. Nothing could be further from the truth; fear “infected” and partially paralyzed MSF as well. Not only did MSF fail to realize that the epidemic was unprecedented even as it was spreading across multiple, frequently heavily pop- ulated locations, but MSF had difficulty scaling up its response once the disease was recognized as being out of control. As described powerfully in the eyewit- ness account by Lindis Hurum, the moment the first health staffer from a part- ner organization in Monrovia was infected with the Ebola virus, MSF itself was on the verge of deciding the risk was too great and pulling out. On a more institutional level, some of the MSF resources were also paralyzed by fear. MSF is organized as an international conglomeration of five semiauton- omous “operational centers,” each with its own medical, logistical, and human resource capacity to respond to emergencies. As the majority of the Ebola experts were located in the Brussels operational center, the coordination for the response was allocated there. It quickly became apparent, however, that the scale of the epidemic required resources from the other centers as well, but this was slow in coming. Fear was a clear internal factor in this delayed response: fear of staff contamination, fear of lack of expertise, and fear of lack of resources. Finally, the fear of being literally as well as figuratively overwhelmed by the epidemic when it was at its peak in the summer of 2014 pushed MSF to take yet another unprecedented step: to make the first call in the history of MSF for a military intervention in an epidemic response.
Recommended publications
  • Fighting Ebola: Voices from the Frontline Documenting the Experiences of East African Deployed Experts Who Volunteered to Fight Ebola in West Africa Implemented By
    Fighting Ebola: Voices from the Frontline Documenting the experiences of East African deployed experts who volunteered to fight Ebola in West Africa Implemented by: Fighting Ebola: Voices from the Frontline Documenting the experiences of East African deployed experts who volunteered to fight Ebola in West Africa Contents Introduction . 6 Foreword from the Hon . Jesca Eriyo . 9 Foreword from Dr Zabulon Yoti . .. 10 Foreword from Dr Jackson Amone . 12 Foreword from Dr Irene Lukassowitz . 13 George Acire . 14 Rebecca Racheal Apolot . 17 Sarah Awilo . 22 Dr Mwaniki Collins . 24 Charles Draleku . 26 Emmanuel Ejoku .. 28 Dr Madina Hussein . 31 Loveness Daniel Isojick . 34 Dr Abdulrahman Said Kassim . 36 Teddy Kusemererwa . .. 40 Liliane Luwaga . 43 Dr Appolinaire Manirafasha . 46 Dr Landry Mayigane . 48 James Mugume . 50 Dr Monica Musenero . 52 Doreen Nabawanuka . 55 Dr Bella Nihorimbere . 56 Teresia Wairimu Thuku . 57 Tony Walter Onena . 59 Acknowledgements . 61 4 Fighting Ebola: Voices from the Frontline 5 Introduction ccording to the World Health Organization (WHO), Others, seeing scenes of death and devastation on their The East African Community Secretariat, in collaboration the Ebola epidemic that occurred in West Africa television screens, just felt compelled to do whatever they with the Federal Government of Germany through the Abetween 2014 and 2016 killed over 11,000 people could to help . Given that so many West African health GIZ-coordinated Support to Pandemic Preparedness in out of the almost 30,000 that were infected . From one
    [Show full text]
  • Targeting Ebola 2015
    Agenda of Targeting Ebola 2015 May 28-29, 2015 Institut Pasteur - Paris, France www.targeting-ebola.com Welcome Note On behalf of the Targeting Infectious Diseases Committee, the Institut Pasteur, the COPED and the Task Force for Ebola in France, it is our pleasure to announce the organization of the International Congress on Targeting Ebola 2015 which will be held on May 28-29, 2015 at Pasteur Institute, Paris, France. The World Health Organization (WHO) was notified on March 23, 2014, of an outbreak of EVD in Guinea. The disease soon spread to the bordering countries of Liberia and Sierra Leone, which are the most severely affected countries. On August 8, 2014, the epidemic was declared a “public health emergency of international concern” (WHO Ebola Response Team, NEJM 2014, 371, 1481). Suspected cases of EVD have since been reported in seven affected countries (Guinea, Liberia, Nigeria, Senegal, Sierra Leone, Spain, and the United States of America). Unprecedented in scale and geographical distribution since the identification of Ebola in 1976, the current epidemic has an apparent overall case-fatality ratio of about 70%; but it is suspected that many more cases have gone unrecorded. On May 2015, more than 10.000 deaths and 30.000 cases had been reported in Sierra Leone, Liberia and Guinea, according to the WHO. Globally, the situation is improving. The epidemic is over in Liberia, however in Guinea and Sierra Leone, the initial decline observed a few weeks ago is stable with approximately 20 new cases / week. The vast majority of cases are reported from the western prefecture of Forecariah, which borders the Sierra Leonean district of Kambia.
    [Show full text]
  • Clinical Trial Protocol Sponsored by OCRPRO
    PREVAIL IV: Double-blind, Randomized, Two-phase, Placebo-controlled, Phase II Trial of GS-5734 to Assess the Antiviral Activity, Longer-term Clearance of Ebola Virus, and Safety in Male Ebola Survivors with Evidence of Ebola Virus Persistence in Semen NIAID Protocol Number: 16-I-N137 Version Number: 10.0 Date: May 13, 2019 Investigational New Drug (IND) Number: 130621 IND Sponsor: Office of Clinical Research Policy and Regulatory Operations (OCRPRO), Division of Clinical Research (DCR), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) Local Liberian Medical Officer: Ian Wachekwa, MD Safety Medical Officer John F. Kennedy Hospital 21 Street, Sinkor Monrovia, Liberia [email protected] (t) +231880890907 Sponsor Medical Monitor: Alan Lifson, MD, MPH Professor, Division of Epidemiology and Community Health School of Public Health University of Minnesota 1300 S. Second St., Ste. 300 Minneapolis, MN 55454 (t) 612-626-9697 (f) 612-624-0315 [email protected] Pharmaceutical Support Provided by: Gilead Sciences, Inc. PREVAIL IV Version 10.0 13 May 2019 Conducted by: Liberia-US Joint Clinical Research Partnership also known as the Partnership for Research on Ebola Virus in Liberia (PREVAIL) Page 2 of 77 PREVAIL IV Version 10.0 13 May 2019 Key Roles NIH Principal Investigator: Elizabeth S. Higgs, MD, MIA, DTMH Division of Clinical Research, NIAID [email protected] (c) +301-768-3947 skype: libby.higgs2 Liberian Principal Investigator: Dehkontee Gayedyu-Dennis, MD PREVAIL [email protected] (t) +231-886-538-810
    [Show full text]
  • Chapter 1 BEFORE EBOLA
    10/12/2017 Preparing for a Crisis: Lessons Learned at Emory Before, During, and After Ebola Jay B. Varkey, MD On behalf of the Chapter 1 BEFORE EBOLA 2 1 10/12/2017 The Story of Emile Meliandou, Guinea, December 2013 Photograph by Suzanne Beukes, UNICEF The Story of Emile Meliandou, Guinea, December 2013 AM Saéz et al, EMBO Mole Med 2015 2 10/12/2017 The Story of Emile Meliandou, Guinea, December 2013 The Story of Emile Meliandou, Guinea, December 2013 AM Saéz et al, EMBO Mole Med 2015 3 10/12/2017 The Story of Emile Meliandou, Guinea, December 2013 Photograph by Suzanne Beukes, UNICEF Spread of a “Cholera‐Like Illness” MeliandouConakry, 12/2013 – 3/2014 S Baize, N Engl J Med 2014 4 10/12/2017 Ebola Virus Disease (EVD) Spread to Liberia and Sierra Leone 4/2014 ELWA Ebola Treatment Unit (ETU) Monrovia, Liberia 6/2014 – 7/2014 Photograph by Bethany Fankhauser, SIM 5 10/12/2017 ELWA ETU Monrovia, Liberia 6/2014 – 7/2014 Photograph by Bethany Fankhauser, SIM ELWA ETU Monrovia, Liberia July 2014 • 40 patients with EVD treated • 39 of 40 died • July 22‐23: 2 American humanitarians working in the ELWA ETC develop a fever…. • Initially treated for malaria • Laboratory testing confirmed Ebola Virus Disease 6 10/12/2017 Ebola Virus Disease and Emory July 30, 2014 • Emory University Hospital was asked to receive the first patients with confirmed Ebola virus disease to be treated in the United States • 2 American humanitarians had become infected while working in an ETU in Monrovia, Liberia • Patient 1: 33 yo male physician • Patient 2: 59 yo female medical missionary • Expected arrival time unclear but Emory was asked to be ready to receive the 1st patient within 72 hours.
    [Show full text]
  • “If You Don't Find Anything, You Can't Eat” – Mining Livelihoods and Income, Gender Roles, and Food Choices In
    Resources Policy 70 (2021) 101939 Contents lists available at ScienceDirect Resources Policy journal homepage: http://www.elsevier.com/locate/resourpol “If you don’t findanything, you can’t eat” – Mining livelihoods and income, gender roles, and food choices in northern Guinea Ronald Stokes-Walters a,d,*, Mohammed Lamine Fofana b, Joseph Lamil´e Songbono c, Alpha Oumar Barry c, Sadio Diallo c, Stella Nordhagen b,e, Laetitia X. Zhang a, Rolf D. Klemm a,b, Peter J. Winch a a Department of International Health, Johns Hopkins Bloomberg School of Public Health – 615 N Wolfe St, Baltimore, MD, 21205, USA b Helen Keller International – One Dag Hammarskjold Plaza, Floor 2, New York, NY, 10017, United States c Julius Nyerere University of Kankan, Kankan, Guinea d Action Against Hunger USA, One Whitehall St, Second Floor, New York NY, 10004, United States e Global Alliance for Improved Nutrition (GAIN), Rue de Vermont 37-39, 1202, Geneva, Switzerland ARTICLE INFO ABSTRACT Keywords: Artisanal and small-scale mining (ASM) continues to grow as a viable economic activity in sub-Saharan Africa. Artisanal mining The health and environmental impacts of the industry, notably linked to the use of potentially toxic chemicals, Food choice has been well documented. What has not been explored to the same extent is how pressures associated with ASM Women’s workload affect food choices of individuals and families living in mining camps. This paper presents research conducted in Income instability 18 mining sites in northern Guinea exploring food choices and the various factors affecting food decision-making Guinea practices. Two of the most influentialfactors to emerge from this study are income variability and gender roles.
    [Show full text]
  • Kinase Inhibitors and Nucleoside Analogues As Novel Therapies to Inhibit HIV-1 Or ZEBOV Replication
    Kinase Inhibitors and Nucleoside Analogues as Novel Therapies to Inhibit HIV-1 or ZEBOV Replication by Stephen D. S. McCarthy A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Department of Laboratory Medicine and Pathobiology University of Toronto © Copyright by Stephen D. S. McCarthy (2017) Kinase Inhibitors and Nucleoside Analogues as Novel Therapies to Inhibit HIV-1 or ZEBOV Replication Stephen D.S. McCarthy Doctor of Philosophy Graduate Department of Laboratory Medicine and Pathobiology University of Toronto 2017 Abstract Without a vaccine for Human Immunodeficiency Virus type 1 (HIV-1), or approved therapy for treating Zaire Ebolavirus (ZEBOV) infection, new means to treat either virus during acute infection are under intense investigation. Repurposing tyrosine kinase inhibitors of known specificity may not only inhibit HIV-1 replication, but also treat associated inflammation or neurocognitive disorders caused by chronic HIV-1 infection. Moreover, tyrosine kinase inhibitors may effectively treat other infections, including ZEBOV. In addition, established nucleoside/nucleotide analogues that effectively inhibit HIV-1 infection, could also be repurposed to inhibit ZEBOV replication. In this work the role of two host cell kinases, cellular protoncogene SRC (c-SRC) and Protein Tyrosine Kinase 2 Beta (PTK2B), were found to have key roles during early HIV-1 replication in primary activated CD4+ T-cells ex vivo. siRNA knockdown of either kinase increased intracellular reverse transcripts and decreased nuclear proviral integration, suggesting they act at the level of pre-integration complex (PIC) formation or PIC nuclear translocation. c-SRC siRNA knockdown consistently reduced p24 levels of IIIB(X4) and Ba-L(R5) infection, or luciferase ii activity of HXB2(X4) or JR-FL(R5) recombinant viruses, prompting further drug inhibition studies of this kinase.
    [Show full text]
  • A Case-Study Approach to Investigate Transmission, Co-Infection, And
    Louisiana State University LSU Digital Commons LSU Doctoral Dissertations Graduate School 5-20-2019 A Case-study Approach to Investigate Transmission, Co-infection, and Clinical Sequelae During Epidemics of Dengue and Ebola Virus Disease Jennifer Elizabeth Giovanni [email protected] Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations Part of the Clinical Epidemiology Commons, Epidemiology Commons, Immunology of Infectious Disease Commons, International Public Health Commons, and the Virology Commons Recommended Citation Giovanni, Jennifer Elizabeth, "A Case-study Approach to Investigate Transmission, Co-infection, and Clinical Sequelae During Epidemics of Dengue and Ebola Virus Disease" (2019). LSU Doctoral Dissertations. 4931. https://digitalcommons.lsu.edu/gradschool_dissertations/4931 This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU Doctoral Dissertations by an authorized graduate school editor of LSU Digital Commons. For more information, please [email protected]. A CASE-STUDY APPROACH TO INVESTIGATE TRANSMISSION, CO-INFECTION, AND CLINICAL SEQUELAE DURING EPIDEMICS OF DENGUE AND EBOLA VIRUS DISEASE A Dissertation Submitted to the Graduate Faculty of the Louisiana State University and Agricultural and Mechanical College in partial fulfillment of the requirements for the degree of Doctor of Philosophy in The Department of Pathobiological Sciences by Jennifer Elizabeth Giovanni B.S., Missouri
    [Show full text]
  • Scientific Coordinator's Report
    P L E C N E W S A N D V I E W S No. 14 NOVEMBER 1999 PRINCIPAL SCIENTIFIC COORDINATOR’S REPORT 1 Highlights of the period April–November 1999 The new trend: helping to restore diversity 2 Demonstrating the value of agrodiversity in Ghana 3 New approaches, new methods, new mind-sets 3 Advances in survey methodology 4 Methodological papers in this issue 4 ‘Vive WAPLEC: Vive le PLEC’: Guinée September 1999 5 The workshop at Pita A visit to Moussaya, upper Niger 5 General remarks 6 MAY 1999 UNU/PLEC-BAG MEETING: SUMMARY AND DATA FORMS 7 D.J. Zarin, with inputs from Guo Huijun, Lewis Enu-Kwesi and Liang Luohui ATTRIBUTES REQUIRED OF THE NEW EXPERT 8 Comments by Professor E. Laing PAPER FROM THE DEMONSTRATION ACTIVITIES ADVISORY TEAM (DAT) 11 DAT facilitating the exchange of experiences in demonstration activities Miguel Pinedo-Vásquez SOME PLEC DEFINITIONS, WITH CODES FOR DATA-BASE PURPOSES 17 from the Editors A DIARY OF MEETINGS ATTENDED BY PLEC MEMBERS, MARCH– 18 NOVEMBER 1999 PAPERS BY PROJECT MEMBERS Mapping of settlements in an evolving PLEC demonstration site in Northern Ghana: an 19 example in collaborative and participatory work The late A.S. Abdulai, E.A. Gyasi and S.K. Kufogbe with assistance of P.K. Adraki, F. Asante, M.A. Asumah, B.Z. Gandaa, B.D. Ofori and A.S. Sumani Agrodiversity highlights in East Africa 25 F. Kaihura, R. Kiome, M. Stocking, A. Tengberg and J. Tumuhairwe An enlargement of PLEC work in Mexico 33 edited from a proposal to PLEC by Carlos Arriaga-Jordán A DIRECTORY OF PLEC DEMONSTRATION SITES, with date of firm 38 establishment, names of cluster leaders and e-mail and fax addresses P L E C N E W S A N D V I E W S No.
    [Show full text]
  • REPUBLIC of GUINEA Labor–Justice–Solidarity
    REPUBLIC OF GUINEA Labor–Justice–Solidarity MINISTRY OF AGRICULTURE AND LIVESTOCK NATIONAL STRATEGY FOR THE DEVELOPMENT OF RICE GROWING APRIL 2009 Table of contents LIST OF ACRONYMS AND ABBREVIATIONS 5 SUMMARY 6 I. INTRODUCTION 8 II. REVIEWING THE RICE SECTOR 9 2.1. The policy position of rice 10 2.2 Preferences and demand estimates 10 2.3 Typology and number of rice farmers, processors and marketers 11 2.4. Gender dimensions 13 2.5. Comparative advantage of national rice production 14 III. CHALLENGES AND OPPORTUNITIES 14 3.1. The potential of local rice for rural poverty reduction and economic growth 14 3.2. The land system 15 3.3. Social issues 16 3.4. Trans-border and regional issues 16 3.5. Knowledge and lessons learnt from R&D in rice 16 VI. PRIORITY AREAS AND PERSPECTIVES 17 4.1. Ranking by order of priority in terms of potential contribution to national production 17 4.2. Identification and ranking specific environmental challenges and related opportunities by order of priority 18 4.3. Identification of policy challenges/opportunities 20 4.3.1. Policy challenges 20 4.3.1. Opportunities 21 V. VISION AND FRAMEWORK OF THE NATIONAL RICE STRATEGY 21 5.1. Objectives of rice production 21 5.5.1. Overall target: 21 5.5.2. Quantified objectives: 21 5.2.3. Strategy development phase 23 5.2.4. Key interventions 24 5.2.5 Scientists, technicians and agricultural advisory agents in 2008 and beyond 25 5.2.6. Governance of the Rice Growing Development Strategy 25 5.2.7.
    [Show full text]
  • Exposure to Ebola Virus and Risk for Infection with Malaria Parasites, Rural Gabon Jessica L
    Exposure to Ebola Virus and Risk for Infection with Malaria Parasites, Rural Gabon Jessica L. Abbate, Pierre Becquart, Eric Leroy, Vanessa O. Ezenwa,1 Benjamin Roche1 diseases (1) and the high frequency of Plasmodium An association between malaria and risk for death spp. co-infection among patients undergoing treat- among patients with Ebola virus disease has suggested ment for confirmed EVD 2( ). At the individual level, within-host interactions between Plasmodium falciparum parasites and Ebola virus. To determine whether such several retrospective epidemiology studies of pa- an interaction might also influence the probability of ac- tients undergoing treatment for confirmed EVD have quiring either infection, we used a large snapshot sur- attempted to determine whether concurrent malaria veillance study from rural Gabon to test if past exposure affects patient outcomes. In Sierra Leone (3) and at to Ebola virus is associated with current infection with 1 Ebola treatment center in Liberia (4), mortality risk Plasmodium spp. during nonepidemic conditions. We was much higher among Ebola patients who were co- found a strong positive association, on population and infected with Plasmodium parasites than among pa- individual levels, between seropositivity for antibodies tients who were not co-infected, and a study in Guin- against Ebola virus and the presence of Plasmodium ea found that adverse outcomes were higher among parasites in the blood. According to a multiple regres- EVD patients with higher P. falciparum parasite loads sion model accounting for other key variables, antibodies than among those with lower levels of parasitemia (5). against Ebola virus emerged as the strongest individual- level risk factor for acquiring malaria.
    [Show full text]
  • 1 Republique De Guinee
    Évaluation Finale du Projet « Renforcement de la Gestion Décentralisée de l’environnement UNDP-GUINEE 2018 pour répondre aux objectifs des Conventions de Rio en Guinée – RGDE » REPUBLIQUE DE GUINEE ____________________________________________________________________ ____________________________________________________________________________________ « Renforcement de la Gestion Décentralisée de l’Environnement pour répondre aux objectifs des Conventions de Rio en Guinée (RGDE-GIN- PIMS-4963 ; ID : 00093877) » ___________________ Rapport d’Évaluation Finale Soumis au PNUD-Guinée Maison Commune, Commune de Matam, Coléah Corniche Sud, Rue MA 002 Conakry, Guinée Par Dr Syaka SADIO, Consultant International, Chef d’équipe Et Alphonse Ngom, Consultant national Août 2018 1 Évaluation Finale du Projet « Renforcement de la Gestion Décentralisée de l’environnement UNDP-GUINEE 2018 pour répondre aux objectifs des Conventions de Rio en Guinée – RGDE » REMERCIEMENTS Les consultants tiennent à exprimer leurs sincères remerciements aux autorités du gouvernement de la Guinée et particulièrement le Ministère de l’Environnement, des Eaux et Forêts (MEEF) et le Programme pour l’environnement et le Développement Durable (PEDD) pour les dispositions prises pour faciliter cette mission et l’atteinte des résultats attendus. Nous remercions tout particulièrement le Bureau du PNUD-Guinée, le Directeur pays et le Directeur Adjoint pays, qui n’ont ménagé aucun effort pour donner des orientations claires à la mission. Aussi, que l’ensemble du personnel, trouve ici l’expression de nos meilleurs sentiments, pour la confiance portée en nous pour conduire l’évaluation terminale du projet, et plus particulièrement Mr. Mamadou Ciré Camara, Team Leader de l’Unité Environnement et Énergie et son équipe, notamment Mamadou kalidou Diallo, chargé du suivi à l’Unité Environnement et Énergie/PNUD, Mr Mamadou Diallo du Procurement -PNUD.
    [Show full text]
  • February 2020 Vol 26, No 2, February 2020
    ® February 2020 Purchase and partial gift from the Catherine and Ralph Benkaim Collection; Severance and Greta Millikin Purchase Fund. Public domain digital image courtesy of The Cleveland Museum of Modern Art, Cleveland, Ohio Cleveland, Art, Modern of Museum Cleveland The of courtesy image digital domain Public Fund. Purchase Millikin Greta and Severance Collection; Benkaim Ralph and Catherine the from gift partial and Purchase Opaque watercolor, ink, and gold on paper. 10 1/4 in x 6 15/16 in/26 cm x 17.6 cm. cm. 17.6 x cm in/26 15/16 6 x in 1/4 10 paper. on gold and ink, watercolor, Opaque , Possibly Maru Ragini from a Ragamala, 1650–80. 1650–80. Ragamala, a from Ragini Maru Possibly , A Rajput Warrior with Camel with Warrior Rajput A Artist Unknown. Unknown. Artist Coronaviruses Vol 26, No 2, February 2020 EMERGING INFECTIOUS DISEASES Pages 191–400 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Centers for Disease Control and Prevention (CDC) Mailstop D61, Atlanta, GA 30329-4027 Official Business Penalty for Private Use $300 Return Service Requested ISSN 1080-6040 Peer-Reviewed Journal Tracking and Analyzing Disease Trends Pages 191–400 EDITOR-IN-CHIEF D. Peter Drotman ASSOCIATE EDITORS EDITORIAL BOARD Charles Ben Beard, Fort Collins, Colorado, USA Barry J. Beaty, Fort Collins, Colorado, USA Ermias Belay, Atlanta, Georgia, USA Martin J. Blaser, New York, New York, USA David M. Bell, Atlanta, Georgia, USA Andrea Boggild, Toronto, Ontario, Canada Sharon Bloom, Atlanta, Georgia, USA Christopher Braden, Atlanta, Georgia, USA Richard Bradbury, Melbourne, Australia Arturo Casadevall, New York, New York, USA Mary Brandt, Atlanta, Georgia, USA Kenneth G.
    [Show full text]